Standing in for a kidney, MXene materials could give dialysis patients the freedom to move

For more than 3 million people around the world, kidney failure is a life-altering diagnosis, if not a life-threatening one. While about 17 percent of people in the U.S. with end-stage kidney disease are now getting transplants, the average time spent waiting is 3-5 years. And much of that time is consumed by planning for, receiving and recovering from treatment. […]

Continue reading »

Fewer dialysis patients facing leg amputations

(HealthDay)—Losing a leg is one of the most traumatic consequences of advanced kidney disease, but the risk of amputations has dropped significantly since 2000, a new study finds. Between 2000 and 2014, amputations among U.S. patients with end-stage kidney disease who were receiving dialysis were cut by 51 percent. Despite the decrease, however, almost half of patients who had amputations […]

Continue reading »

Using hepatitis C-infected donor kidneys could reduce time on dialysis for transplant patients with HCV

Transplanting hepatitis C (HCV)-infected dialysis patients with organs from HCV-positive donors and then treating the infection after transplantation is more effective, costs less and will shorten wait times for donated organs, according to a computer analysis conducted by physician-researchers at the University of Cincinnati (UC) College of Medicine. The findings are available online in the Annals of Internal Medicine. The […]

Continue reading »

For dialysis patients with AFib, a newer blood thinner may provide a safer option

People with irregular heartbeat due to a condition called atrial fibrillation, are often prescribed blood thinners to reduce the risk of blood clots that can cause a stroke. But for those who are also on dialysis for kidney failure, the already-difficult choice of blood thinner can seem like a guessing game without a right answer. One reason: patients on dialysis […]

Continue reading »